Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.

Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group.

Mult Scler Relat Disord. 2019 Oct 4;36:101430. doi: 10.1016/j.msard.2019.101430. [Epub ahead of print]

PMID:
31610404
2.

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Clerico M, De Mercanti SF, Signori A, Iudicello M, Cordioli C, Signoriello E, Lus G, Bonavita S, Lavorgna L, Maniscalco GT, Curti E, Lorefice L, Cocco E, Nociti V, Mirabella M, Baroncini D, Mataluni G, Landi D, Petruzzo M, Lanzillo R, Gandoglia I, Laroni A, Frangiamore R, Sartori A, Cavalla P, Costantini G, Sormani MP, Capra R.

Neurotherapeutics. 2019 Aug 26. doi: 10.1007/s13311-019-00776-7. [Epub ahead of print]

PMID:
31452081
3.

Partial Thromboplastin Time: Accurate Measurement Through Evidence-Based Practice.

Drummond S, Gotskie G, Landi D, Lindberg J, Ross K, Siak S, Reslink M, Chubeck C, Brown R, Agostino L.

Clin J Oncol Nurs. 2019 Aug 1;23(4):431-433. doi: 10.1188/19.CJON.431-433.

PMID:
31322626
4.

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.

Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N.

J Clin Invest. 2019 Jul 2;129(8):3464. doi: 10.1172/JCI131246. eCollection 2019 Jul 2. No abstract available.

5.

Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis.

Cipollini M, Luisi S, Piomboni P, Luddi A, Landi D, Melaiu O, Figlioli G, Garritano S, Cappelli V, Viganò P, Gemignani F, Petraglia F, Landi S.

Fertil Steril. 2019 Aug;112(2):343-352.e1. doi: 10.1016/j.fertnstert.2019.04.011. Epub 2019 Jun 27.

PMID:
31256999
6.

The implications of a new paradigm of care on the built environment. The Humanitas© Deventer model: Innovative practice.

Landi D, Smith G.

Dementia (London). 2019 Apr 25:1471301219845480. doi: 10.1177/1471301219845480. [Epub ahead of print]

PMID:
31023081
7.

Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability.

Siotto M, Filippi MM, Simonelli I, Landi D, Ghazaryan A, Vollaro S, Ventriglia M, Pasqualetti P, Rongioletti MCA, Squitti R, Vernieri F.

Front Neurosci. 2019 Feb 11;13:86. doi: 10.3389/fnins.2019.00086. eCollection 2019.

8.

Emotional processing in RRMS patients: Dissociation between behavioural and neurophysiological response.

Migliore S, Curcio G, Porcaro C, Cottone C, Simonelli I, D'aurizio G, Landi D, Palmieri MG, Ghazaryan A, Squitieri F, Filippi MM, Vernieri F.

Mult Scler Relat Disord. 2019 Jan;27:344-349. doi: 10.1016/j.msard.2018.11.019. Epub 2018 Nov 19.

PMID:
30472414
9.

Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.

Stampanoni Bassi M, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R, Finardi A, Marfia GA, Centonze D, Buttari F.

J Neurol. 2018 Nov;265(11):2540-2547. doi: 10.1007/s00415-018-8994-5. Epub 2018 Aug 28.

PMID:
30167879
10.

Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status.

Thompson EM, Landi D, Ashley D, Keir ST, Bigner D.

J Neurooncol. 2018 Nov;140(2):261-268. doi: 10.1007/s11060-018-2975-5. Epub 2018 Aug 17.

PMID:
30120661
11.

Novel case of recurrent intraventricular atypical central neurocytoma with prominent gangliogliomatous differentiation in a 10-year-old boy with 10 years of follow up.

Tan CL, Landi D, Fuchs H, McLendon RE.

Neuropathology. 2018 Oct;38(5):542-548. doi: 10.1111/neup.12502. Epub 2018 Jul 24.

PMID:
30039530
12.

Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.

Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, Gasperini C, Haggiag S, Landi D, Marfia GA, Millefiorini E, Monteleone F, Nociti V, Salvetti M, Sgarlata E, Pozzilli C.

CNS Drugs. 2018 Oct;32(10):963-970. doi: 10.1007/s40263-018-0543-3.

PMID:
30022464
13.

Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.

Landi D, Ragonese P, Prosperini L, Nociti V, Haggiag S, Cortese A, Fantozzi R, Pontecorvo S, Ferraro E, Buscarinu MC, Mataluni G, Monteleone F, Salvetti M, Di Battista G, Francia A, Millefiorini E, Gasperini C, Mirabella M, Salemi G, Boffa L, Pozzilli C, Centonze D, Marfia GA.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1272-1278. doi: 10.1136/jnnp-2018-318468. Epub 2018 Jul 3.

PMID:
29970387
14.

MitraClip Implantation to Treat Early Recurrence of Mitral Regurgitation After Percutaneous Direct Annuloplasty With Cardioband.

Ristalli F, Meucci F, Stolcova M, Valente S, Landi D, Di Mario C.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1416-1417. doi: 10.1016/j.jcin.2018.04.049. Epub 2018 Jun 27. No abstract available.

15.

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.

Stampanoni Bassi M, Iezzi E, Marfia GA, Simonelli I, Musella A, Mandolesi G, Fresegna D, Pasqualetti P, Furlan R, Finardi A, Mataluni G, Landi D, Gilio L, Centonze D, Buttari F.

J Neuroinflammation. 2018 Apr 14;15(1):108. doi: 10.1186/s12974-018-1150-4.

16.

Unexpected delayed complete atrioventricular block after Cardioband implantation.

Sorini Dini C, Landi D, Meucci F, Di Mario C.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1201-1204. doi: 10.1002/ccd.27519. Epub 2018 Mar 6.

PMID:
29508515
17.

Investigating the feasibility of a reuse scenario for textile fibres recovered from end-of-life tyres.

Landi D, Gigli S, Germani M, Marconi M.

Waste Manag. 2018 May;75:187-204. doi: 10.1016/j.wasman.2018.02.018. Epub 2018 Feb 14.

PMID:
29454817
18.

Fingolimod reduces the clinical expression of active demyelinating lesions in MS.

Signoriello E, Landi D, Monteleone F, Saccà F, Nicoletti CG, Buttari F, Sica F, Marfia GA, Di Iorio G, Lus G, Centonze D.

Mult Scler Relat Disord. 2018 Feb;20:215-219. doi: 10.1016/j.msard.2018.02.002. Epub 2018 Feb 5.

PMID:
29433094
20.

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

Byrd TT, Fousek K, Pignata A, Szot C, Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K, Landi D, Rainusso N, Hicks J, Powell S, Baker ML, Wels WS, Koch J, Sorensen PH, Deneen B, Ellis MJ, Lewis MT, Hegde M, Fletcher BS, St Croix B, Ahmed N.

Cancer Res. 2018 Jan 15;78(2):489-500. doi: 10.1158/0008-5472.CAN-16-1911. Epub 2017 Nov 28. Erratum in: Cancer Res. 2018 Jun 15;78(12):3403.

21.

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.

Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Squitieri F, Curcio G, Landi D, Palmieri MG, Moffa F, Filippi MM, Vernieri F.

Behav Neurol. 2017;2017:7404289. doi: 10.1155/2017/7404289. Epub 2017 Aug 15.

22.

Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.

Landi D, Albanese M, Buttari F, Monteleone F, Boffa L, Rossi S, Motta C, Puma E, Centonze D.

PLoS One. 2017 Jul 7;12(7):e0165415. doi: 10.1371/journal.pone.0165415. eCollection 2017.

23.

Executive functioning in relapsing-remitting multiple sclerosis patients without cognitive impairment: A task-switching protocol.

Migliore S, Curcio G, Couyoumdjian A, Ghazaryan A, Landi D, Moffa F, Quintiliani L, Squitieri F, Palmieri MG, Filippi MM, Vernieri F.

Mult Scler. 2018 Sep;24(10):1328-1336. doi: 10.1177/1352458517719149. Epub 2017 Jul 5.

PMID:
28675956
24.

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.

Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S.

JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184.

25.

TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis.

Buttari F, Zagaglia S, Marciano L, Albanese M, Landi D, Nicoletti CG, Mercuri NB, Silvestrini M, Provinciali L, Marfia GA, Mori F, Centonze D.

J Neuroimmunol. 2017 Apr 15;305:172-174. doi: 10.1016/j.jneuroim.2017.02.007. Epub 2017 Feb 8.

PMID:
28284340
26.

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.

Landi D, De Rossi N, Zagaglia S, Scarpazza C, Prosperini L, Albanese M, Buttari F, Mori F, Marfia GA, Sormani MP, Capra R, Centonze D; Italian PML study group.

Neurology. 2017 Mar 21;88(12):1144-1152. doi: 10.1212/WNL.0000000000003740. Epub 2017 Feb 22.

27.

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.

Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N.

J Clin Invest. 2016 Aug 1;126(8):3036-52. doi: 10.1172/JCI83416. Epub 2016 Jul 18.

28.

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.

Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Landi D, Palmieri MG, Moffa F, Rinaldi P, Vernieri F, Filippi MM.

Neurol Sci. 2016 Aug;37(8):1261-70. doi: 10.1007/s10072-016-2578-x. Epub 2016 Apr 20.

PMID:
27095052
29.

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.

Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D.

J Neuroinflammation. 2016 Feb 10;13:36. doi: 10.1186/s12974-016-0502-1.

30.

COmparison between COronary THrombus aspiration with Angiojet® or Export® catheter in patients with ST-elevation myocardial infarction submitted to primary angioplasty: The COCOTH Study.

Giglioli C, Cecchi E, Sciagrá R, Baldereschi GJ, Meucci F, Valente S, Chiostri M, Gensini GF, Spini V, Landi D, Romano SM, Calabretta R.

Int J Cardiol. 2016 Jan 15;203:757-62. doi: 10.1016/j.ijcard.2015.03.158. Epub 2015 Mar 17.

PMID:
26590366
31.

Clinical and scintigraphic follow-up of ST-elevation myocardial infarction patients submitted to primary angioplasty and randomized to thrombus aspiration with Angiojet® or Export®.

Giglioli C, Romano SM, Calabretta R, Cecchi E, Gensini GF, Landi D, Chiostri M, Spini V, Sciagrà R.

Int J Cardiol. 2016 Jan 1;202:654-6. doi: 10.1016/j.ijcard.2015.09.105. Epub 2015 Sep 28. No abstract available.

PMID:
26451795
32.

Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.

Wakefield A, Pignata A, Ghazi A, Ashoori A, Hegde M, Landi D, Gray T, Scheurer ME, Chintagumpala M, Adesina A, Gottschalk S, Hicks J, Powell SZ, Ahmed N.

J Neurooncol. 2015 Nov;125(2):307-15. doi: 10.1007/s11060-015-1905-z. Epub 2015 Sep 4.

33.

Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity.

Landi D, Maggio P, Lupoi D, Palazzo P, Altamura C, Falato E, Altavilla R, Vollaro S, Coniglio AD, Tibuzzi F, Passarelli F, Silvestrini M, Pasqualetti P, Vernieri F.

Cerebrovasc Dis. 2015;39(1):23-30. doi: 10.1159/000369292. Epub 2014 Dec 24.

PMID:
25547043
34.

Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy.

Landi D, Hegde M, Ahmed N.

Front Oncol. 2014 Nov 26;4:338. doi: 10.3389/fonc.2014.00338. eCollection 2014. Review.

35.

Nutraceutical properties of chestnut flours: beneficial effects on skeletal muscle atrophy.

Frati A, Landi D, Marinelli C, Gianni G, Fontana L, Migliorini M, Pierucci F, Garcia-Gil M, Meacci E.

Food Funct. 2014 Nov;5(11):2870-82. doi: 10.1039/c4fo00353e.

PMID:
25183412
36.

Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.

Landi D, Vollaro S, Pellegrino G, Mulas D, Ghazaryan A, Falato E, Pasqualetti P, Rossini PM, Filippi MM.

Clin Neurophysiol. 2015 Jan;126(1):165-9. doi: 10.1016/j.clinph.2014.05.031. Epub 2014 Jun 19.

PMID:
25022794
37.

Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI.

Cecchi E, D'Alfonso MG, Chiostri M, Parigi E, Landi D, Valente S, Romano SM, Gensini GF, Giglioli C.

High Blood Press Cardiovasc Prev. 2014 Mar;21(1):37-43. doi: 10.1007/s40292-013-0032-1. Epub 2013 Nov 12.

PMID:
24218158
38.

Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit.

Giglioli C, Spini V, Landi D, Chiostri M, Romano SM, Calabretta R, Gensini GF, Cecchi E.

Acta Cardiol. 2013 Aug;68(4):355-64.

PMID:
24187761
39.

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

Cipollini M, Figlioli G, Garritano S, Bramante S, Maiorano L, Gnudi F, Cecchini A, De Paola F, Damicis L, Frixa T, Landi D, Cancemi L, De Santi C, Melaiu O, Foddis R, Cristaudo A, Bonotti A, Romei C, Elisei R, Pellegrini G, Barale R, Gemignani F, Landi S.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2121-5. doi: 10.1158/1055-9965.EPI-13-0790. Epub 2013 Sep 5.

40.

Hemodynamic effects in patients with atrial fibrillation submitted to electrical cardioversion.

Giglioli C, Nesti M, Cecchi E, Landi D, Chiostri M, Gensini GF, Spini V, Romano SM.

Int J Cardiol. 2013 Oct;168(4):4447-50. doi: 10.1016/j.ijcard.2013.06.150. Epub 2013 Jul 24. No abstract available.

PMID:
23890895
41.

Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on?

Giglioli C, Minelli M, Chiostri M, Landi D, Romano SM, Balzi D, Valente S, Padeletti L, Gensini GF, Cecchi E.

Intern Emerg Med. 2014 Aug;9(5):521-8. doi: 10.1007/s11739-013-0959-1. Epub 2013 Jun 1.

PMID:
23729385
42.

Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis.

Shah N, Rollins M, Landi D, Shah R, Bae J, De Castro LM.

Clin J Pain. 2014 Mar;30(3):266-8. doi: 10.1097/AJP.0b013e318295ec04.

43.

Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment.

Maggio P, Altamura C, Landi D, Migliore S, Lupoi D, Moffa F, Quintiliani L, Vollaro S, Palazzo P, Altavilla R, Pasqualetti P, Errante Y, Quattrocchi CC, Tibuzzi F, Passarelli F, Arpesani R, di Giambattista G, Grasso FR, Luppi G, Vernieri F.

J Neurol Sci. 2013 May 15;328(1-2):58-63. doi: 10.1016/j.jns.2013.02.019. Epub 2013 Mar 17.

PMID:
23510565
44.

Characteristics of abdominal vein thrombosis in children and adults.

Landi D, Beckman MG, Shah NR, Bockenstedt P, Grant AM, Heit JA, Key NS, Kulkarni R, Manco-Johnson M, Moll S, Philipp CS, Andersen JC, Ortel TL.

Thromb Haemost. 2013 Apr;109(4):625-32. doi: 10.1160/TH12-08-0568. Epub 2013 Feb 14.

45.

Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures.

Spini V, Cecchi E, Chiostri M, Landi D, Romano SM, Mattesini A, Gensini GF, Giglioli C.

J Invasive Cardiol. 2013 Feb;25(2):80-4.

46.

Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin.

Dal Monte M, Landi D, Martini D, Bagnoli P.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386(1):15-27. doi: 10.1007/s00210-012-0808-1. Epub 2012 Nov 6.

PMID:
23128854
47.

Report of a young girl with MYH9 mutation and review of the literature.

Landi D, Lockhart E, Miller SE, Datto M, Rehder C, Kanaly A, Thornburg CD.

J Pediatr Hematol Oncol. 2012 Oct;34(7):538-40. Review.

PMID:
23007341
48.

Complex epileptic palilalia: a case report.

Landi D, Benvenga A, Quattrocchi CC, Vollero L, Assenza G, Pellegrino G, Campana C, Tombini M.

Seizure. 2012 Oct;21(8):655-7. doi: 10.1016/j.seizure.2012.06.009. Epub 2012 Jul 7.

49.

Cortico-muscular coherence as an index of fatigue in multiple sclerosis.

Tomasevic L, Zito G, Pasqualetti P, Filippi M, Landi D, Ghazaryan A, Lupoi D, Porcaro C, Bagnato F, Rossini P, Tecchio F.

Mult Scler. 2013 Mar;19(3):334-43. doi: 10.1177/1352458512452921. Epub 2012 Jul 3.

PMID:
22760098
50.

Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk.

Naccarati A, Pardini B, Stefano L, Landi D, Slyskova J, Novotny J, Levy M, Polakova V, Lipska L, Vodicka P.

Carcinogenesis. 2012 Jul;33(7):1346-51. doi: 10.1093/carcin/bgs172. Epub 2012 May 11.

PMID:
22581836

Supplemental Content

Support Center